Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    June 2024
  1. LI W, Liang J, Zhang Z, Lou H, et al
    [Retracted] MicroRNA?329?3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
    Oncol Rep. 2024;51:86.
    PubMed     Abstract available


    April 2024
  2. SHI C, Zhang Z
    [Retracted] MicroRNA?362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
    Oncol Rep. 2024;51:54.
    PubMed     Abstract available


    December 2023
  3. LIU Z, Zhang H, Hu X
    Analysis of the expression and mechanism of follistatin?like protein 1 in cervical cancer.
    Oncol Rep. 2023;50:215.
    PubMed     Abstract available


    November 2023
  4. LIANG H, Luo R, Chen X, Zhao Y, et al
    [Retracted] miR?187 inhibits the growth of cervical cancer cells by targeting FGF9.
    Oncol Rep. 2023;50:195.
    PubMed     Abstract available


    July 2023
  5. LI M, Gao Z, Wang S, Zhao Y, et al
    miR‑27a‑3p upregulation by p65 facilitates cervical tumorigenesis by increasing TAB3 expression and is involved in the positive feedback loop of NF‑kappaB signaling.
    Oncol Rep. 2023;50:132.
    PubMed     Abstract available


    June 2023
  6. YANG J, Gao Y, Yao S, Wan S, et al
    TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.
    Oncol Rep. 2023;49:114.
    PubMed     Abstract available


  7. NDIAYE M, Diop G, Derbois C, Spadoni JL, et al
    Gene expression profiling of peripheral blood mononuclear cells from women with cervical lesions reveals new markers of cancer.
    Oncol Rep. 2023;49:118.
    PubMed     Abstract available


    May 2023
  8. CAUSIN RL, Van Helvoort Lengert A, Gomes INF, De Freitas AJA, et al
    MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression.
    Oncol Rep. 2023;49:109.
    PubMed     Abstract available


    February 2023
  9. GAO Y, Ma X, Lu H, Xu P, et al
    PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.
    Oncol Rep. 2023;49:25.
    PubMed     Abstract available


    January 2023
  10. CHEN D, Cao J, Tian L, Liu F, et al
    [Retracted] Induction of apoptosis by casticin in cervical cancer cells through reactive oxygen species‑mediated mitochondrial signaling pathways.
    Oncol Rep. 2023;49:11.
    PubMed     Abstract available


    November 2022
  11. RAMLI I, Susworo S, Nuranna L, Mansyur M, et al
    Circadian as a prognostic factor for radiation responses in patients with cervical cancer: A nested casecontrol study.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  12. ZHOU L, Li H, Zhang D, Chen L, et al
    OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    October 2022
  13. LIU C, Feng H, Song L, Li S, et al
    Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  14. XING F, Song Z, Cheng Z
    High expression of PDIA4 promotes malignant cell behavior and predicts reduced survival in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    September 2022
  15. WANG Z, He S, Guo P, Guo X, et al
    [Retracted] MicroRNA1297 inhibits metastasis and epithelialmesenchymal transition by targeting AEG1 in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  16. LIAO H, Pan Y, Pan Y, Shen J, et al
    [Retracted] MicroRNA874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    May 2022
  17. XIAO W, Zhou S, Xu H, Li H, et al
    [Corrigendum] NogoB promotes the epithelialmesenchymal transition in HeLa cervical cancer cells via Fibulin5.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    April 2022
  18. ZHANG W, Wang C, Hu X, Lian Y, et al
    Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    December 2021
  19. ZHAO Q, Zhai YX, Liu HQ, Shi YA, et al
    [Retracted] MicroRNA4915p suppresses cervical cancer cell growth by targeting hTERT.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    November 2021
  20. LI Y, Qian X, Lin Y, Tao L, et al
    Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  21. LIU L, Shi W, Xiao X, Wu X, et al
    BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP1 cells via the Rb/E2F1 pathway in cervical carcinoma.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    July 2021
  22. SONG X, Shi B, Huang K, Zhang W, et al
    [Retracted] miR133a inhibits cervical cancer growth by targeting EGFR.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  23. CHU J, Gao J, Wang J, Li L, et al
    Mechanism of hydrogen on cervical cancer suppression revealed by highthroughput RNA sequencing.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    June 2021
  24. DEZEN T, Rossini RR, Spadin MD, Da Cunha Andrade CEM, et al
    Accuracy of MRI for diagnosing pelvic and paraaortic lymph node metastasis in cervical cancer.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    May 2021
  25. WANG J, Xiang F, Liu X, Ma X, et al
    HPV E7 affects the function of cervical cancer cells via the TAL1/lncEBIC/KLHDC7B axis.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  26. YANG X, Du H, Bian W, Li Q, et al
    FOXD3AS1/miR1283p/LIMK1 axis regulates cervical cancer progression.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  27. OUYANG F, Liu J, Xia M, Lin C, et al
    [Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in earlystage cervical cancer.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    April 2021
  28. YOU X, Wang Y, Meng J, Han S, et al
    Exosomal miR663b exposed to TGFbeta1 promotes cervical cancer metastasis and epithelialmesenchymal transition by targeting MGAT3.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available


  29. CHEN J, Chen H, Pan L
    SIRT1 and gynecological malignancies (Review).
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    March 2021
  30. QIN K, Jian D, Xue Y, Cheng Y, et al
    DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
    Oncol Rep. 2021;45:1213-1225.
    PubMed     Abstract available


    February 2021
  31. SHEN Z, Song W, Qian L, Zhu J, et al
    Effect of claudin 1 on cell proliferation, migration and apoptosis in human cervical squamous cell carcinoma.
    Oncol Rep. 2021;45:606-618.
    PubMed     Abstract available


    November 2020
  32. LIU H, Li Y, Zhang J, Wu N, et al
    ErbB2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53responsive microRNA31845p in cervical cancer cells.
    Oncol Rep. 2020 Nov 19. doi: 10.3892/or.2020.7862.
    PubMed     Abstract available


    October 2020
  33. WANG A, Liu L, Yuan M, Han S, et al
    Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
    Oncol Rep. 2020 Oct 21. doi: 10.3892/or.2020.7819.
    PubMed     Abstract available


    July 2020
  34. SI J, Zhang J, Gan L, Guo M, et al
    The effects of the Wnt/betacatenin signaling pathway on apoptosis in HeLa cells induced by carbon ion irradiation.
    Oncol Rep. 2020;44:303-312.
    PubMed     Abstract available


    May 2020
  35. MA HR, Cao L, Wang F, Cheng C, et al
    Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
    Oncol Rep. 2020;43:1536-1546.
    PubMed     Abstract available


    April 2020
  36. ICHIKAWA R, Kawasaki R, Iwata A, Otani S, et al
    MicroRNA1263p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
    Oncol Rep. 2020;43:1300-1308.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.